Browsing byAuthorThivierge, K
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
2012-06-01 | The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria | Skinner-Adams, TS; Peatey, CL; Anderson, K; Trenholme, KR; Krige, D; Brown, CL; Stack, C; Nsangou, DMM; Mathews, RT; Thivierge, K; Dalton, JP; Gardiner, DL |
2012-06-25 | Anti-malaria drug development targeting the M1 alanyl and M17 leucyl aminopeptidases | Thivierge, K; Mathew, RT; Nsangou, DMM; Da Silva, F; Cotton, S; Skinner-Adams, TS; Trenholme, KR; Brown, CL; Stack, CM; Gardiner, DL; Dalton, JP |
2013-01-01 | Cathelicidin-like Helminth Defence Molecules (HDMs): Absence of Cytotoxic, Anti-microbial and Anti-protozoan Activities Imply a Specific Adaptation to Immune Modulation | Thivierge, K; Cotton, S; Schaefer, DA; Riggs, MW; To, J; Lund, ME; Robinson, MW; Dalton, JP; Donnelly, SM |
2012-12-01 | Defense peptides secreted by helminth pathogens: Antimicrobial and/or immunomodulator molecules? | Cotton, S; Donnelly, S; Robinson, MW; Dalton, JP; Thivierge, K |
2020-07-09 | Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs). | Shiels, J; Cwiklinski, K; Alvarado, R; Thivierge, K; Cotton, S; Gonzales Santana, B; To, J; Donnelly, S; Taggart, CC; Weldon, S; Dalton, JP |